SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-21-000029
Filing Date
2021-07-29
Accepted
2021-07-29 16:36:30
Documents
85
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptct-20210630x10q.htm   iXBRL 10-Q 2527967
2 EX-3.1 ptct-20210630ex312113d92.htm EX-3.1 98357
3 EX-31.1 ptct-20210630ex3115d3fd5.htm EX-31.1 10921
4 EX-31.2 ptct-20210630ex31290f854.htm EX-31.2 10723
5 EX-32.1 ptct-20210630ex3216adcea.htm EX-32.1 5932
6 EX-32.2 ptct-20210630ex32256b5b5.htm EX-32.2 6118
  Complete submission text file 0001070081-21-000029.txt   11875233

Data Files

Seq Description Document Type Size
7 EX-101.SCH ptct-20210630.xsd EX-101.SCH 69731
8 EX-101.CAL ptct-20210630_cal.xml EX-101.CAL 85197
9 EX-101.DEF ptct-20210630_def.xml EX-101.DEF 341679
10 EX-101.LAB ptct-20210630_lab.xml EX-101.LAB 708293
11 EX-101.PRE ptct-20210630_pre.xml EX-101.PRE 586668
12 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20210630x10q_htm.xml XML 2473271
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 211127982
SIC: 2834 Pharmaceutical Preparations